Correlation Between Viracta Therapeutics and Johnson Johnson

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Johnson Johnson at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Johnson Johnson into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Johnson Johnson, you can compare the effects of market volatilities on Viracta Therapeutics and Johnson Johnson and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Johnson Johnson. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Johnson Johnson.

Diversification Opportunities for Viracta Therapeutics and Johnson Johnson

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Viracta and Johnson is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Johnson Johnson in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Johnson Johnson and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Johnson Johnson. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Johnson Johnson has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Johnson Johnson go up and down completely randomly.

Pair Corralation between Viracta Therapeutics and Johnson Johnson

Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Johnson Johnson. In addition to that, Viracta Therapeutics is 6.69 times more volatile than Johnson Johnson. It trades about -0.09 of its total potential returns per unit of risk. Johnson Johnson is currently generating about 0.0 per unit of volatility. If you would invest  15,830  in Johnson Johnson on August 23, 2024 and sell it today you would lose (280.00) from holding Johnson Johnson or give up 1.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Viracta Therapeutics  vs.  Johnson Johnson

 Performance 
       Timeline  
Viracta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viracta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Johnson Johnson 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, Johnson Johnson is not utilizing all of its potentials. The latest stock price chaos, may contribute to medium-term losses for the stakeholders.

Viracta Therapeutics and Johnson Johnson Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viracta Therapeutics and Johnson Johnson

The main advantage of trading using opposite Viracta Therapeutics and Johnson Johnson positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Johnson Johnson can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Johnson Johnson will offset losses from the drop in Johnson Johnson's long position.
The idea behind Viracta Therapeutics and Johnson Johnson pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Correlations
Find global opportunities by holding instruments from different markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance